InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Royan Ajay, Director. Officer active across 2 companies, notably Adagio Therapeutics, Inc.. In total, 4 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €21k. History available since 14 March 2025. The latest transaction was filed on 14 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Ajay Royan is a Board Member at Adagio Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategy and oversight of operations. His expertise in biotechnology is valuable for the development of Adagio.